Bryan, Garnier & Co's News

AstraZeneca: Company contact - Saxa/dapa’s CRL remains unclear

BUY, Fair Value  5100p (+23%)
News published on
October Monday 19, 2015



For more information, please contact marketing@bryangarnier.com